Patent Issued for Heterocyclic compounds and uses thereof (USPTO 12059425).

A patent has been issued to Kumquat Biosciences Inc. for heterocyclic compounds and their uses in treating diseases, particularly cancer. The compounds are designed to target Ras proteins, including wildtype Ras and mutant Ras proteins, to reduce Ras signaling output. The patent claims a specific compound formula and its pharmaceutically acceptable salt or solvate. This invention addresses the need for new therapeutics and diagnostics that can specifically target Ras and provides potential advantages for the diagnosis, prognosis, and treatment of various diseases. [Extracted from the article]